IP Library Patent Application 13033483
Patent Application
App. No. 13/033,483

METHODS FOR TREATING PROSTATITIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/033,483
Abstract

It has been discovered that silodosin is effective in treating patients having symptoms associated with prostatitis with silodosin or a pharmaceutically acceptable salt thereof. In a preferred embodiment, patients are treated with 4 mg once daily.

Claims (14)

1 . A method of treating a patient having symptoms of prostatitis and/or pelvic pain syndrome comprising administering to said patient an effective amount of silodosin or a pharmaceutically acceptable salt thereof.

2 . The method of claim 1 , wherein the effective amount is about 2 mg to about 8 mg.

3 . The method of claim 1 , wherein the effective amount is about 4 mg to about 8 mg.

4 . The method of claim 1 , wherein the effective amount is 4 mg to 8 mg.

5 . The method of claim 1 , wherein the effective amount is about 4 mg.

6 . The method of claim 1 , wherein the effective amount is delivered in a divided daily dose.

7 . The method of claim 1 , wherein the effective amount is delivered in a single daily dose.

8 . The method of claim 5 , wherein the effective amount is delivered in a twice-daily dose.

9 . The method of claim 5 , wherein the effective amount is delivered in a single daily dose.

10 . The method of claim 1 , wherein a pharmaceutical composition is administered comprising silodosin and at least one excipient.

11 . The method of claim 1 , wherein a pharmaceutical composition is administered comprising silodosin and an antibiotic.

12 . A method of treating a patient having symptoms of chronic prostatitis/chronic pelvic pain syndrome comprising administering to said patient an effective amount of silodosin or a pharmaceutically acceptable salt thereof.

13 . The method of claim 12 , wherein the effective amount is about 2 mg to about 8 mg.

14 . The method of claim 12 , wherein the effective amount is about 4 mg.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: ALLERGAN FINANCE LLC (F/K/A ACTAVIS, INC.)
To: ALLERGAN SALES, LLC
Reel/Frame 039895/0389 →
CHANGE OF NAME Recorded Aug 16, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 031028/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2011
From: HOEL, GARY; HILL, LAWRENCE; CARAMELLI, KIM
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 026108/0148 →